BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37861491)

  • 21. Circular RNA MAT2B Promotes Glycolysis and Malignancy of Hepatocellular Carcinoma Through the miR-338-3p/PKM2 Axis Under Hypoxic Stress.
    Li Q; Pan X; Zhu D; Deng Z; Jiang R; Wang X
    Hepatology; 2019 Oct; 70(4):1298-1316. PubMed ID: 31004447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma.
    Martin SP; Fako V; Dang H; Dominguez DA; Khatib S; Ma L; Wang H; Zheng W; Wang XW
    J Exp Clin Cancer Res; 2020 Jun; 39(1):99. PubMed ID: 32487192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COX-2 induces apoptosis-resistance in hepatocellular carcinoma cells via the HIF-1α/PKM2 pathway.
    Wang Q; Lu D; Fan L; Li Y; Liu Y; Yu H; Wang H; Liu J; Sun G
    Int J Mol Med; 2019 Jan; 43(1):475-488. PubMed ID: 30365092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma.
    Feng J; Li J; Wu L; Yu Q; Ji J; Wu J; Dai W; Guo C
    J Exp Clin Cancer Res; 2020 Jul; 39(1):126. PubMed ID: 32631382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.
    Chen YL; Song JJ; Chen XC; Xu W; Zhi Q; Liu YP; Xu HZ; Pan JS; Ren JL; Guleng B
    World J Gastroenterol; 2015 Aug; 21(30):9093-102. PubMed ID: 26290635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CRAF Methylation by PRMT6 Regulates Aerobic Glycolysis-Driven Hepatocarcinogenesis via ERK-Dependent PKM2 Nuclear Relocalization and Activation.
    Wong TL; Ng KY; Tan KV; Chan LH; Zhou L; Che N; Hoo RLC; Lee TK; Richard S; Lo CM; Man K; Khong PL; Ma S
    Hepatology; 2020 Apr; 71(4):1279-1296. PubMed ID: 31469916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA HClnc1 facilitates hepatocellular carcinoma progression by regulating PKM2 signaling and indicates poor survival outcome after hepatectomy.
    Zhu Q; Lei Z; Xu C; Zhang Z; Yu Z; Cheng Z; Xiao P; Li S; Yu W; Zhou J
    Cancer Med; 2023 Jul; 12(13):14526-14544. PubMed ID: 37212467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.
    Yang W; Wang B; Yu Q; Liu T; Li T; Tian T; Jin A; Ding L; Chen W; Wang H; Xian J; Pan B; Zhou J; Fan J; Yang X; Guo W
    Theranostics; 2022; 12(14):6189-6206. PubMed ID: 36168627
    [No Abstract]   [Full Text] [Related]  

  • 29. Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis.
    Feng J; Dai W; Mao Y; Wu L; Li J; Chen K; Yu Q; Kong R; Li S; Zhang J; Ji J; Wu J; Mo W; Xu X; Guo C
    J Exp Clin Cancer Res; 2020 Jan; 39(1):24. PubMed ID: 32000827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyruvate kinase M2 prevents apoptosis via modulating Bim stability and associates with poor outcome in hepatocellular carcinoma.
    Hu W; Lu SX; Li M; Zhang C; Liu LL; Fu J; Jin JT; Luo RZ; Zhang CZ; Yun JP
    Oncotarget; 2015 Mar; 6(9):6570-83. PubMed ID: 25788265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA ZFPM2-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by regulating the miR-576-3p/HIF-1α axis.
    Song Y; Jin X; Liu Y; Wang S; Bian F; Zhao Q; Shi H; Gao Z
    Anticancer Drugs; 2021 Sep; 32(8):812-821. PubMed ID: 34102651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TRIM35 Interacts with pyruvate kinase isoform M2 to suppress the Warburg effect and tumorigenicity in hepatocellular carcinoma.
    Chen Z; Wang Z; Guo W; Zhang Z; Zhao F; Zhao Y; Jia D; Ding J; Wang H; Yao M; He X
    Oncogene; 2015 Jul; 34(30):3946-56. PubMed ID: 25263439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of Pyruvate Kinase M2 in Tumor Tissues Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma.
    Zhao R; Li L; Yang J; Niu Q; Wang H; Qin X; Zhu N; Shi A
    Pathol Oncol Res; 2020 Apr; 26(2):853-860. PubMed ID: 30852741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A feedback loop between NONHSAT024276 and PTBP1 inhibits tumor progression and glycolysis in HCC by increasing the PKM1/PKM2 ratio.
    Li Y; Chen X; Huang H; Liao L; Chong H; Li G; Yuan T; Lu W; Deng S; Huang Q
    Cancer Sci; 2023 Apr; 114(4):1519-1540. PubMed ID: 36529521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
    Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
    J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phage display library selection of a hypoxia-binding scFv antibody for liver cancer metabolic marker discovery.
    Liu J; Zhang Q; Chen H; Gao Z; Li Y; Sun Z; Xiang R; Zhang S
    Oncotarget; 2016 Jun; 7(25):38105-38121. PubMed ID: 27203546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PKM2 regulates hepatocellular carcinoma cell epithelial-mesenchymal transition and migration upon EGFR activation.
    Fan FT; Shen CS; Tao L; Tian C; Liu ZG; Zhu ZJ; Liu YP; Pei CS; Wu HY; Zhang L; Wang AY; Zheng SZ; Huang SL; Lu Y
    Asian Pac J Cancer Prev; 2014; 15(5):1961-70. PubMed ID: 24716919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PPP1R26 drives hepatocellular carcinoma progression by controlling glycolysis and epithelial-mesenchymal transition.
    Yang Y; Ren P; Liu X; Sun X; Zhang C; Du X; Xing B
    J Exp Clin Cancer Res; 2022 Mar; 41(1):101. PubMed ID: 35292107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signal transducer and activator of transcription 3 promotes the Warburg effect possibly by inducing pyruvate kinase M2 phosphorylation in liver precancerous lesions.
    Bi YH; Han WQ; Li RF; Wang YJ; Du ZS; Wang XJ; Jiang Y
    World J Gastroenterol; 2019 Apr; 25(16):1936-1949. PubMed ID: 31086462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shikonin differentially regulates glucose metabolism via PKM2 and HIF1α to overcome apoptosis in a refractory HCC cell line.
    Yang W; Liu J; Hou L; Chen Q; Liu Y
    Life Sci; 2021 Jan; 265():118796. PubMed ID: 33220292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.